Literature DB >> 7811859

Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study.

C J Fichtenbaum1, K F Woeltje, W G Powderly.   

Abstract

We conducted a case-control study to determine the incidence and clinical features of and risk factors for Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus (HIV). Twenty-five patients who had 37 episodes of P. aeruginosa infection from 1990 through 1992 were identified. Most of the patients (92%) were homosexual men with low CD4+ lymphocyte counts and a history of AIDS. The annual incidence rates of P. aeruginosa infection were 3.5% (1990), 6.3% (1991), and 8.7% (1992). Most infections were community-acquired (68%) and involved the respiratory tract (73%). Patients were more likely than HIV-infected controls to have AIDS and had more AIDS-defining opportunistic illnesses. The overall mortality was 36%. Recurrent episodes were common (39%). We conclude that P. aeruginosa infections may be an increasing problem in patients with extremely advanced HIV infection. Clinicians should consider including antibiotics with activity against P. aeruginosa in the empirical treatment for suspected bacterial infection in patients with advanced HIV infection.

Entities:  

Mesh:

Year:  1994        PMID: 7811859     DOI: 10.1093/clinids/19.3.417

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections.

Authors:  K P Rumbaugh; J A Griswold; B H Iglewski; A N Hamood
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey.

Authors:  R Manfredi; A Nanetti; M Ferri; F Chiodo
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

3.  Pseudomonas aeruginosa phage lysate as an immunobiological agent. 1. Selection of Pseudomonas aeruginosa clinical strains for phage lysate preparation.

Authors:  G Sekaninová; M Kolárová; J Pillich; J Seménka; H Slavíková; D Kubícková; V Zajícová
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

4.  Impaired macrophage phagocytosis of apoptotic neutrophils in patients with human immunodeficiency virus type 1 infection.

Authors:  Donato Torre; Luisa Gennero; F M Baccino; Filippo Speranza; Gilberto Biondi; Agostino Pugliese
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 5.  Human Immunodeficiency Virus Infection and Host Defense in the Lungs.

Authors:  Tysheena P Charles; Judd E Shellito
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

6.  Pseudomonas aeruginosa AlgR controls cyanide production in an AlgZ-dependent manner.

Authors:  William L Cody; Christopher L Pritchett; Adriana K Jones; Alexander J Carterson; Debra Jackson; Anders Frisk; Matthew C Wolfgang; Michael J Schurr
Journal:  J Bacteriol       Date:  2009-03-06       Impact factor: 3.490

7.  Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection.

Authors:  H B Tang; E DiMango; R Bryan; M Gambello; B H Iglewski; J B Goldberg; A Prince
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

Review 8.  Current treatment of pseudomonal infections in the elderly.

Authors:  Georgios Pappas; Kaiti Saplaoura; Matthew E Falagas
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

9.  Ionic gold demonstrates antimicrobial activity against Pseudomonas aeruginosa strains due to cellular ultrastructure damage.

Authors:  Miguel Reyes Torres; Anthony J Slate; Steven F Ryder; Maliha Akram; Conrado Javier Carrascosa Iruzubieta; Kathryn A Whitehead
Journal:  Arch Microbiol       Date:  2021-03-29       Impact factor: 2.552

10.  Pseudomonas aeruginosa causing inflammatory mass of the nasopharynx in an immunocompromised HIV infected patient: A mimic of malignancy.

Authors:  Michael John Gale; Maria Susana Maritato; Yaw-Ling Chen; Saif S Abdulateef; Jose E Ruiz
Journal:  IDCases       Date:  2015-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.